Advertisement

Acute Ventricular Arrhythmias in Myocardial Infarction — An Example of Catecholamine-Mediated “Stress”?

  • L. H. Opie
  • M. Thomas
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 46)

Abstract

Acute ventricular arrhythmias in myocardial infarction are thought to be dependent, at least in part, on the activity of the adrenergic nervous system. When a heart has its catecholamine stores depleted by prior treatment with reserpine or by cardiac denervation, the incidence of early “malignant” arrhythmias decreases(1). Conversely, intravenous injections of catecholamines produce ventricular arrhythmias in animals with pre-existing myocardial ischemia but not in those without(2). The purpose of this paper is to examine the principles relating catecholamine adrenergic activity to the development of ventricular arrhythmias.

Keywords

Free Fatty Acid Acute Myocardial Infarction Ventricular Arrhythmia Action Potential Duration Coronary Artery Ligation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ebert PA, Vanderbeek RB, Allgood RJ, Sabiston DC Jr: Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation. Cardiovasc Res (4): 141–147, 1970.PubMedCrossRefGoogle Scholar
  2. 2.
    Opie LH, Lubbe WF: Catecholamine-mediated arrhythmias in acute myocardial infarction: experimental evidence and role of beta-blockade. SA Med J (56): 871–880, 1979.Google Scholar
  3. 3.
    Opie LH, Muller C, Nathan D, Daries P, Higginson L, Lubbe WF: Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation. In: Advances in Cyclic Nucleotide Research, Vol 12. Raven Press, New York, 1980, pp 63–69.Google Scholar
  4. 4.
    Nordrehaug JE, von der Lippe G: Hypokalaemia and ventricular fibrillation in acute myocardial infarction. Brit Heart J (50): 525–529, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Kurien VA, Yates PA, Oliver MF: Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction. Lancet (2): 185–187, 1969.PubMedCrossRefGoogle Scholar
  6. 6.
    Opie LH, Norris RM, Thomas M, Holland AJ, Owen P, Van Noorden S: Failure of high concentrations of free fatty acids to provoke arrhythmias in experimental myocardial infarction. Lancet (1): 818–822, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Didier JP, Moreau D, Opie LH: Effect of glucose and of fatty acid on rhythm, enzyme release and oxygen uptake in isolated working rat heart with coronary artery ligation. J Mol Cell Cardiol (12): 1191–1206, 1980.PubMedCrossRefGoogle Scholar
  8. 8.
    Gupta DK, Jewitt DE, Young R, Hartog M, Opie LH: Increased plasma free fatty acids and their significance in patients with acute myocardial infarction. Lancet (2): 1209–1213, 1969.PubMedCrossRefGoogle Scholar
  9. 9.
    Tansey MJB, Opie LH: Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet (2): 419–422, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Oppie LH, Bricknell OL: Role of glycolytic flux in effect of glucose in decreasing fatty-acid-induced release of lactate dehydrogenase from isolated coronary ligated rat heart. Cardiovasc Res (13) 693–702, 1979.CrossRefGoogle Scholar
  11. 11.
    Opie LH, Owen P, Riemersma RA: Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Europ J Clin Invest (3): 419–435, 1973.PubMedCrossRefGoogle Scholar
  12. 12.
    Serur JR, Urschel CW, Sonnenblick EH, La Raia PJ: Experimental myocardial ischemia. III. Protective effect of glucose on myocardial function. J Mol Cell Cardiol (8): 521–531, 1976.CrossRefGoogle Scholar
  13. 13.
    Russell DC, Oliver MF: Effect of glucose on ventricular vulnerability during acute myocardial ischaemia in the dog. J Mol Cell Cardiol (11): 31–44, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Hess ML, Manson NH: Molecular oxygen: Friend and foe. J Mol Cell Cardiol (16): in press, 1984.Google Scholar
  15. 15.
    Harris AS, Bisteni A, Russell RA, Brigham JC, Firestone JE: Excitatory factors in ventricular tachycardia resulting from myocardial ischemia. Science (119): 200–203, 1954.PubMedCrossRefGoogle Scholar
  16. 16.
    Kleber A: Extracellular potassium accumulation in acute myocardial ischemia. J Mol Cell Cardiol (16): 389–394, 1984.PubMedCrossRefGoogle Scholar
  17. 17.
    Podzuweit T, Dalby AJ, Cherry GW, Opie LH: Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol (10): 81–94, 1978.PubMedCrossRefGoogle Scholar
  18. 18.
    Lubbe WF, Podzuweit T, Daries PS, Opie LH: The role of cyclic adenosine monophosphate in adrenergic effects on vulnerability to fibrillation in the isolated perfused rat heart. J Clin Invest (61): 1260–1269, 1978.PubMedCrossRefGoogle Scholar
  19. 19.
    Opie LH, Nathan D, Lubbe WF: Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol (43): 131–148, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    ppie LH, Muller C, Nathan D, Daries P, Lubbe WF: Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation. Adv Cycl Nucleotide Res (12): 63–69, 1980.Google Scholar
  21. 21.
    Opie LH, Thandroyen FT: Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts. Fed Proc (42): 2465–2469, 1983.PubMedGoogle Scholar
  22. 22.
    Sperelakis N: Properties of calcium-dependent slow action potentials: Their possible role in arrhythmias. In: Opie LH (ed) Calcium Antagonists and Cardiovascular Disease. Raven Press, New York, 1984, pp 277–291.Google Scholar
  23. 23.
    Reuter H: Electrophysiology of calcium channels in the heart. In: Opie LH (ed) Calcium Antagonists and Cardiovascular Disease. Raven Press, New York, 1984, pp 43–51.Google Scholar
  24. 24.
    Clusin WT, Bristow MR, Bain DS, Schroeder JS, Jaillon P, Brett P, Harrison DC: The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog. Circ Res (50): 518–526, 1982.PubMedGoogle Scholar
  25. 25.
    Opie LH, Thandroyen F, Muller C, Daries P. Catecholamines, cyclic AMP and arrhythmias. Role for Ca2+ and Ca2+-antagonist agents. In: Riemersma R, Oliver MF (eds) Catecholamines in the non-ischaemic and ischaemic myocardium. Elsevier/North Holland Biomedical Press, New York, 1982, pp 203–222.Google Scholar
  26. 26.
    Gulker H, Thale J, Heuer H, Rose D, Bender F: Comparative antiarrhythmic action of diltiazem during early and late phase ventricular arrhythmias. Europ Heart J (5)(Abstr Suppl 1): 13, 1984.Google Scholar
  27. 27.
    Parratt JR: Inhibitors of the slow calcium current and early ventricular arrhythmias. In: Parratt JR (ed) Early arrhythmias resulting from myocardial ischaemia. Mechanisms and prevention by drugs. MacMillan, London, 1982, pp 329–346.Google Scholar
  28. 28.
    Allen DG, Orchard CH: Measurements of intracellular calcium concentration in heart muscle: the effects of inotropic interventions and hypoxia. J Mol Cell Cardiol (16): 117–128, 1984.PubMedCrossRefGoogle Scholar
  29. 29.
    Bricknell OL, Daries PS, Opie LH: A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol (13): 941–945, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Saman S, Opie LH: Mechanism of reduction of action potential duration of ventricular myocardium by exogenous lactate. J Mol Cell Cardiol (16): 659–662, 1984.PubMedCrossRefGoogle Scholar
  31. 31.
    Corr PB, Gross RW, Sobel BE: Arrhythmogenic amphiphilic lipids and the myocardial cell membrane. J Mol Cell Cardiol (14): 619–626, 1982.PubMedCrossRefGoogle Scholar
  32. 32.
    Steenbergen C, Jennings RB: Relationship between lysophospholipid accumulation and plasma membrane injury during total in vitro ischemia in dog heart. J Mol Cell Cardiol (16): 605–621, 1984.PubMedCrossRefGoogle Scholar
  33. 33.
    Muller CA, Opie LH: The effect of beta-blockade on myocardial tissue levels of cyclic AMP and the incidence of ventricular fibrillation (VF) after coronary artery ligation in the pig. J Mol Cell Cardiol (11)(Suppl 2): 40, 1979.Google Scholar
  34. 34.
    Mueller HS, Ayres SM: Metabolic responses of heart in acute myocardial infarction in man. Am J Cardiol (42): 363–371, 1978.PubMedCrossRefGoogle Scholar
  35. 35.
    Staszewska-Barczak J: The reflex stimulation of catecholamine secretion during the acute stage of myocardial infarction in the dog. Clin Sci (41): 419–439, 1971.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • L. H. Opie
  • M. Thomas

There are no affiliations available

Personalised recommendations